Market Place
Sourcing Support
Enforcement Report - Week of March 29, 2023
29 Mar 2023 //
FDA
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Teva Pharma`s Generic Dofetilide Receives Approval in U.S.
15 Apr 2022 //
FDA
Vgyaan`s Generic Dofetilide Receives Approval in the U.S.
14 Apr 2022 //
FDA
Granules India ’s Generics Dofetilide Receives Approvals In US
19 Oct 2021 //
FDA
Granules India receives USFDA approval for Dofetilide capsules
18 Oct 2021 //
BUSINESS-STANDARD
MSN`s Generic Dofetilide Receives Approval in US
01 Feb 2020 //
FDA
Riconpharma`s Generic Dofetilide Receives Approval in US
28 Dec 2019 //
FDA
Biocon extends licensing pact with Equillium for itolizumab
13 Dec 2019 //
ECONOMIC TIMES
Repurposing Pfizer`s heart rhythm drug Tikosyn to treat PAH
13 Dec 2019 //
FIERCE BIOTECH
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Aurobindo Pharma`s Generic Dofetilide Receives Approval in US
25 Jan 2019 //
FDA
Aurobindo Pharma`s Generic Dofetilide Receives Approval in US
22 Jan 2019 //
FDA
Sun Pharma`s Generic Dofetilide Receives Approval in US
10 Oct 2018 //
FDA
Par Pharm`s Generic Dofetilide Receives Approval in US
10 Oct 2018 //
FDA
Mayne Pharm receives US FDA marketing nod for generic Tikosyn
09 Jun 2016 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.